T cell receptor engagement of peptide-major histocompatibility complex class I does not modify CD8 binding

Molecular Immunology

Volumn 45, Issue 9, 2008, Pages 2700-2709

  Cole, David K ^a   Dunn, Steven M ^b   Sami, Malkit ^b   Boulter, Jonathan M ^a   Jakobsen, Bent K ^b   Sewell, Andrew K ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b Medigene UK Limited   (United Kingdom)

Author keywords

Antigen recognition; CD8 co receptor; KD; Surface plasmon resonance; T cell; TCR

Indexed keywords

CD8 ANTIGEN; HLA A2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; KINETICS; PRIORITY JOURNAL; PROTEIN FUNCTION; T LYMPHOCYTE; WILD TYPE;

ANTIGENS, CD8; BINDING SITES; HLA-A2 ANTIGEN; HUMANS; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES, CYTOTOXIC;

EID: 40849095843     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2007.12.009     Document Type: Article

References (32)

1. Boulter J.M., Glick M., Todorov P.T., Baston E., Sami M., Rizkallah P., and Jakobsen B.K. Stable, soluble T-cell receptor molecules for crystallization and therapeutics. Protein Eng. 16 (2003) 707-711
2. Buslepp J., Wang H., Biddison W.E., Appella E., and Collins E.J. A correlation between TCR V alpha docking on MHC and CD8 dependence: implications for T cell selection. Immunity 19 (2003) 595-606
3. Cantor H., and Boyse E.A. Functional subclasses of T-lymphocytes bearing different Ly antigens. I. The generation of functionally distinct T-cell subclasses is a differentiative process independent of antigen. J. Exp. Med. 141 (1975) 1376-1389
4. Chen J.L., Stewart-Jones G., Bossi G., Lissin N.M., Wooldridge L., Choi E.M., Held G., Dunbar P.R., Esnouf R.M., Sami M., Boulter J.M., Rizkallah P., Renner C., Sewell A., van der Merwe P.A., Jakobsen B.K., Griffiths G., Jones E.Y., and Cerundolo V. Structural and kinetic basis for heightened immunogenicity of T cell vaccines. J. Exp. Med. 201 (2005) 1243-1255
5. Cole D.K., Pumphrey N.J., Boulter J.M., Sami M., Bell J.I., Gostick E., Price D.A., Gao G.F., Sewell A.K., and Jakobsen B.K. Human TCR-binding affinity is governed by MHC class restriction. J. Immunol. 178 (2007) 5727-5734
6. Cole D.K., Rizkallah P.J., Boulter J.M., Sami M., Vuidepot A.L., Glick M., Gao F., Bell J.I., Jakobsen B.K., and Gao G.F. Computational design and crystal structure of an enhanced affinity mutant human CD8 alphaalpha coreceptor. Proteins 67 (2007) 65-74
7. Cole D.K., Rizkallah P.J., Gao F., Watson N.I., Boulter J.M., Bell J.I., Sami M., Gao G.F., and Jakobsen B.K. Crystal structure of HLA-A*2402 complexed with a telomerase peptide. Eur. J. Immunol. 36 (2006) 170-179
8. Dunn S.M., Rizkallah P.J., Baston E., Mahon T., Cameron B., Moysey R., Gao F., Sami M., Boulter J., Li Y., and Jakobsen B.K. Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide-MHC without increasing apparent cross-reactivity. Protein Sci. 15 (2006) 710-721
9. Gao G.F., Gerth U.C., Wyer J.R., Willcox B.E., O'Callaghan C.A., Zhang Z., Jones E.Y., Bell J.I., and Jakobsen B.K. Assembly and crystallization of the complex between the human T cell coreceptor CD8alpha homodimer and HLA-A2. Protein Sci. 7 (1998) 1245-1249
10. Gao G.F., Tormo J., Gerth U.C., Wyer J.R., McMichael A.J., Stuart D.I., Bell J.I., Jones E.Y., and Jakobsen B.K. Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2. Nature 387 (1997) 630-634
11. Garboczi D.N., Ghosh P., Utz U., Fan Q.R., Biddison W.E., and Wiley D.C. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384 (1996) 134-141
12. Garcia K.C., Scott C.A., Brunmark A., Carbone F.R., Peterson P.A., Wilson I.A., and Teyton L. CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes. Nature 384 (1996) 577-581
13. Gostick E., Cole D.K., Hutchinson S.L., Wooldridge L., Tafuro S., Laugel B., Lissina A., Oxenius A., Boulter J.M., Price D.A., and Sewell A.K. Functional and biophysical characterization of an HLA-A*6801-restricted HIV-specific T cell receptor. Eur. J. Immunol. 37 (2007) 479-486
14. Hampl J., Chien Y.H., and Davis M.M. CD4 augments the response of a T cell to agonist but not to antagonist ligands. Immunity 7 (1997) 379-385
15. Holler P.D., and Kranz D.M. Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation. Immunity 18 (2003) 255-264
16. Janeway Jr. C.A. The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation. Annu. Rev. Immunol. 10 (1992) 645-674
17. Karlsson R., Katsamba P.S., Nordin H., Pol E., and Myszka D.G. Analyzing a kinetic titration series using affinity biosensors. Anal. Biochem. 349 (2006) 136-147
18. Kern P., Hussey R.E., Spoerl R., Reinherz E.L., and Chang H.C. Expression, purification, and functional analysis of murine ectodomain fragments of CD8alphaalpha and CD8alphabeta dimers. J. Biol. Chem. 274 (1999) 27237-27243
19. Kjer-Nielsen L., Clements C.S., Brooks A.G., Purcell A.W., Fontes M.R., McCluskey J., and Rossjohn J. The structure of HLA-B8 complexed to an immunodominant viral determinant: peptide-induced conformational changes and a mode of MHC class I dimerization. J. Immunol. 169 (2002) 5153-5160
20. Kjer-Nielsen L., Clements C.S., Purcell A.W., Brooks A.G., Whisstock J.C., Burrows S.R., McCluskey J., and Rossjohn J. A structural basis for the selection of dominant alphabeta T cell receptors in antiviral immunity. Immunity 18 (2003) 53-64
21. Laugel B., van den Berg H.A., Gostick E., Cole D.K., Wooldridge L., Boulter J.M., Milicic A., Price D.A., and Sewell A.K. Different T cell receptor affinity thresholds and CD8 coreceptor dependency govern cytotoxic T lymphocyte activation and tetramer binding properties. J. Biol. Chem. 282 (2007) 23799-23810
22. Li Y., Moysey R., Molloy P.E., Vuidepot A.L., Mahon T., Baston E., Dunn S., Liddy N., Jacob J., Jakobsen B.K., and Boulter J.M. Directed evolution of human T-cell receptors with picomolar affinities by phage display. Nat. Biotechnol. 23 (2005) 349-354
23. Luescher I.F., Vivier E., Layer A., Mahiou J., Godeau F., Malissen B., and Romero P. CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes. Nature 373 (1995) 353-356
24. MacDonald H.R., Glasebrook A.L., and Cerottini J.C. Clonal heterogeneity in the functional requirement for Lyt-2/3 molecules on cytolytic T lymphocytes: analysis by antibody blocking and selective trypsinization. J. Exp. Med. 156 (1982) 1711-1722
25. Madden D.R., Garboczi D.N., and Wiley D.C. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 75 (1993) 693-708
26. Madrenas J., Chau L.A., Smith J., Bluestone J.A., and Germain R.N. The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide-MHC molecule ligands. J. Exp. Med. 185 (1997) 219-229
27. Purbhoo M.A., Li Y., Sutton D.H., Brewer J.E., Gostick E., Bossi G., Laugel B., Moysey R., Baston E., Liddy N., Cameron B., Bennett A.D., Ashfield R., Milicic A., Price D.A., Classon B.J., Sewell A.K., and Jakobsen B.K. The HLA A*0201-restricted hTERT540-548 peptide is not detected on tumor cells by a CTL clone or a high-affinity T-cell receptor. Mol. Cancer Ther. 6 (2007) 2081-2091
28. Sami M., Rizkallah P.J., Dunn S., Molloy P., Moysey R., Vuidepot A., Baston E., Todorov P., Li Y., Gao F., Boulter J.M., and Jakobsen B.K. Crystal structures of high affinity human T-cell receptors bound to peptide major histocompatibility complex reveal native diagonal binding geometry. Protein. Eng. Des. Sel. 20 (2007) 397-403
29. Saper M.A., Bjorkman P.J., and Wiley D.C. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. J. Mol. Biol. 219 (1991) 277-319
30. Wooldridge L., van den Berg H.A., Glick M., Gostick E., Laugel B., Hutchinson S.L., Milicic A., Brenchley J.M., Douek D.C., Price D.A., and Sewell A.K. Interaction between the CD8 coreceptor and major histocompatibility complex class I stabilizes T cell receptor-antigen complexes at the cell surface. J. Biol. Chem. 280 (2005) 27491-27501
31. Wyer J.R., Willcox B.E., Gao G.F., Gerth U.C., Davis S.J., Bell J.I., van der Merwe P.A., and Jakobsen B.K. T cell receptor and coreceptor CD8 alphaalpha bind peptide-MHC independently and with distinct kinetics. Immunity 10 (1999) 219-225
32. Yachi P.P., Ampudia J., Zal T., and Gascoigne N.R. Altered peptide ligands induce delayed CD8-T cell receptor interaction-a role for CD8 in distinguishing antigen quality. Immunity 25 (2006) 203-211